University of Minnesota. Driven to Discover.
The drug, zoliflodacin, was highly effective in treating urogenital and rectal infections but not pharyngeal cases.
The arrival of the inevitable untreatable cases is being sped up by rising rates of gonorrhea and other STDs.
The new data mark a 4th straight year of "steep and sustained" increases.
Men had higher expression of antimicrobial resistance genes, a finding that may have implications for the growing threat of resistant gonorrhea.
The results show a wide diversity of gonorrhea strains both within and among nations.
The cases indicate a need for action to preserve the last remaining effective treatment.
The isolate shows high-level resistance to azithromycin and resistance to ceftriaxone.
A separate paper details ceftriaxone-resistant gonorrhea cases in Australia.
The CDC issued a foreboding warning, noting that all progress made toward STD elimination in the United States has lost traction.
New data raise the specter of completely resistant Neisseria gonorrhoeae strains, and options are few.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.